

![]() |
|||||||||||||
|
| All | Since 2020 | |
| Citation | 6651 | 4087 |
| h-index | 26 | 21 |
| i10-index | 174 | 83 |
Search
News & Updation
PHARMACEUTICAL CO-CRYSTALS: A STRATEGIC APPROACH TO MODIFY PHYSIOCHEMICAL PROPERTIES OF DRUGS
Jasnoor Kaur Cheema*, Jessica, Jatin Singh, Arvinder Kaur and Satvinder Kaur
ABSTRACT The definition of co-crystals proposed by the FDA in the draft guidance states that they are: “Solids that are crystalline materials composed of two or more than two molecules in the same crystal lattice.” Wherever, there is not one accepted definition of co-crystals corresponding to the scientific literature.[1] Keywords: . [Download Article] [Download Certifiate] |
